Joe Blog

Top 10 Companies Likely to Transact: August 17 - 21

Written by Morgan Holycross, Marketing Manager | Aug 22, 2026, 1:30:00 AM

Data sourced from Joe, the private fund performance platform powered by Dakota. Learn More | Request Access

Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.

Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.

Joe, powered by Dakota, centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.

Below is our weekly roundup of ten PE- or VC-backed companies from the week of August 17 - 21 that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.

Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.

1. Vistaar Financial Services Private Limited

Vistaar Financial Services Private Limited is a non-banking financial company (NBFC) based in Bengaluru, India, specializing in providing customized financial solutions to micro, small, and medium enterprises (MSMEs). Established in 2010, the company offers a range of products, including business loans, home loans, gold loans, and personal loans, aiming to empower businesses and fuel MSME growth across India.

  • Sector: Financials
  • Last known funding round: Seed Venture, $156M, August 2025
  • Why timing suggests a near-term transaction: A $156M Seed round is unusually large for a financials company, suggesting Vistaar raised balance-sheet capital to originate and hold loans rather than just fund operations — this scale likely provides extended runway, making a near-term follow-on raise less imminent than typical seed-stage burn profiles would suggest.

2. Arnatar Therapeutics

Arnatar Therapeutics is a biopharmaceutical company specializing in the development of novel nucleic acid-based therapies. Utilizing their proprietary DARGER™ platform, they focus on both silencing disease-causing genes and upregulating beneficial proteins to address unmet needs in cardiometabolic, liver, central nervous system (CNS), and kidney diseases. Their approach aims to provide precise and durable treatments for conditions where current therapies are insufficient.

  • Sector: Health Care
  • Last known funding round: Series A Venture, $52M, August 2025
  • Why timing suggests a near-term transaction: A $52M Series A in August 2025 is sized to fund early clinical development for a health care company, and at roughly 12 months post-close, Arnatar is nearing the 18–24 month preclinical-to-clinic runway that typically drives biotech firms back to market for a Series B.

3. Sesh+

Sesh+ is a Canadian consumer products company that develops and manufactures tobacco-free nicotine pouches. Its products provide an alternative nicotine delivery format for adult consumers, with a range of flavors and formulations designed as substitutes for traditional tobacco products.

  • Sector: Consumer Staples
  • Last known funding round: Series A Venture, $40M, September 2025
  • Why timing suggests a near-term transaction: Sesh+'s $40M Series A announced in September 2025 places the company approximately 12 months removed from its most recent financing by late 2026, aligning with the period when well-capitalized Series A consumer companies may begin preparing for their next growth round. As distribution, customer adoption, and brand partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.

4. Sola Security

Sola Security is a cybersecurity company that provides a self-serve platform for building and managing customized security solutions. Its AI-powered platform enables organizations to analyze threats, automate security workflows, and create security tools using natural language or code, making cybersecurity more accessible and scalable.

  • Sector: Information Technology
  • Last known transaction date: Series A Venture, $35M, September 2025
  • Why timing suggests a near-term transaction: Sola Security's $35M Series A announced in September 2025 places the company approximately 12 months removed from its most recent financing by late 2026, aligning with the period when well-capitalized Series A cybersecurity companies may begin preparing for their next growth round. As enterprise adoption, platform capabilities, and strategic security partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.

5. Leal Therapeutics

Leal Therapeutics is a biotechnology company dedicated to developing novel precision medicines for patients with central nervous system (CNS) disorders. Their lead programs include LTX-001, an oral small molecule targeting glutamate biology for schizophrenia, and LTX-002, an antisense oligonucleotide (ASO) targeting lipid metabolism for amyotrophic lateral sclerosis (ALS). Both programs are on track for Investigational New Drug (IND) applications in 2024, with clinical data expected in 2025. Additional pipeline programs address Alzheimer's disease, epilepsy, and depression.

  • Sector: Health Care
  • Last known funding round: Series A Venture, $30M, August 2025
  • Why timing suggests a near-term transaction: A $30M Series A in August 2025 is sized to fund early clinical development for a health care company, and at roughly 12 months post-close, Leal is approaching the 18–24 month preclinical-to-clinic runway that typically drives biotech firms back to market for a Series B.

Knowing which companies are close to a transaction is half the picture. Joe, powered by Dakota, shows you how the funds holding them have actually performed. Request access.

6. Holo

Holo is a fintech company founded in 2019, headquartered in Dubai, United Arab Emirates. The company operates as a digital mortgage platform, offering an end-to-end solution for property buyers in the Middle East. Holo's mission is to simplify the home-buying process by providing users with access to over 500 mortgage products from all banks in the UAE, enabling them to secure the best mortgage deals efficiently and without stress.

  • Sector: Financials
  • Last known funding round: Series A Venture, $22M, August 2025
  • Why timing suggests a near-term transaction: A $22M Series A close positions Holo with a reasonable runway, but fintech companies typically pursue a Series B within 18-24 months to scale customer acquisition and product breadth, placing a follow-on raise in the window of late 2026 into 2027.

7. Vouched

Vouched is an AI-powered identity verification platform that helps businesses authenticate customers, prevent fraud, and meet regulatory requirements. Its real-time decisioning technology combines proprietary AI models and data verification to streamline identity checks across industries including financial services, healthcare, and automotive.

  • Sector: Information Technology
  • Last known transaction date: Series A Venture, $17M, September 2025
  • Why timing suggests a near-term transaction: Vouched's $17M Series A announced in September 2025 places the company approximately 12 months removed from its most recent financing by late 2026, aligning with the period when Series A identity and security technology companies may begin preparing for their next growth round. As enterprise adoption, identity verification capabilities, and strategic partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.

8. Plural Energy

Plural Energy is a financial technology company that provides a digital investment platform for renewable energy infrastructure. Its platform uses blockchain-enabled technology to connect investors with clean energy projects, helping expand access to renewable infrastructure investments while improving liquidity and capital formation.

  • Sector: Utilities
  • Last known funding round: Seed Venture, $7.13M, September 2025
  • Why timing suggests a near-term transaction: Plural Energy's $7.13M seed round announced in September 2025 places the company approximately 12 months removed from its initial financing by late 2026, aligning with the period when seed-stage energy and fintech companies may begin preparing for their next raise. As platform adoption, transaction activity, and clean energy partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or early acquisition interest.

9. Oway

Oway is a Myanmar-based travel agency offering a comprehensive suite of services, including real-time flight and hotel bookings, taxi-hailing, and e-payment solutions through its mobile application and website. The company aims to streamline travel experiences for both business enterprises and consumers.

  • Sector: Consumer Discretionary
  • Last known transaction date: Seed Venture, $4M, August 2025
  • Why timing suggests a near-term transaction: A $4M seed close is a lean raise for a consumer-facing company, where customer acquisition and product development costs can compress runway quickly, making Oway one of the more urgent candidates for a Series A conversation likely becoming timely in late 2026.

10. Payment Labs

Payment Labs is a fintech company founded in 2020, headquartered in Van Nuys, California. It specializes in providing automated global payment solutions, enabling startups and small to medium-sized businesses (SMBs) to manage payments in over 150 currencies across 180 countries. The platform offers services such as pay-ins, payouts, and tax compliance, aiming to simplify complex payment processes for its clients.

  • Sector: Financials
  • Last known funding round: Seed Venture, $3.25M, August 2025
  • Why timing suggests a near-term transaction: At approximately 12 months post-raise on its $3.25M Seed, Payment Labs is entering the typical 12–18 month fundraising cycle for financials/fintech companies, where regulatory and licensing costs alongside customer acquisition spend tend to compress runway ahead of a Series A push.

Use Joe's Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does

Joe’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.

Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.

This dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.

Filter by sector, geography, funding stage, last transaction date, or parent sponsor to build the list that matches your mandate.

To explore more companies likely to transact, request access to Joe.